Module 8 introduction_new video

Loading...

En provenance du cours de University of Geneva

Disease Screening in Public Health

54 notes

University of Geneva

Disease Screening in Public Health

54 notes

Current and future public health is characterized by the increase of chronic and degenerative diseases, corresponding to the worldwide ageing of the population. The increasing prevalence of these conditions together with the long incubation period of the chronic diseases and the continual technological innovations, offer new opportunities to develop strategies for early diagnosis. Public Health has an important mandate to critically assess the promises and the pitfalls of disease screening strategies. This MOOC will help you understand important concepts for screening programs that will be explored through a series of examples that are the most relevant to public health today. We will conclude with expert interviews that explore future topics that will be important for screening. By the end of this MOOC, students should have the competency needed to be involved in the scientific field of screening, and understand the public health perspective in screening programs. This MOOC has been designed by the University of Geneva and the University of Lausanne. This MOOC has been prepared under the auspices of the Ecole romande de santé publique (www.ersp.ch) by Prof. Fred Paccaud, MD, MSc, Head of the Institute of Social and Preventive Medicine in Lausanne (www.iumsp.ch), in collaboration with Professor Antoine Flahault, MD, PhD, head of the Institute of Global Health, Geneva (https://www.unige.ch/medecine/isg/en/) and Prof. Gillian Bartlett-Esquilant (McGill University, Quebec/ Institute of Social and Preventive Medicine, Lausanne).

À partir de la leçon

Evaluation, Planning, Implementation and the Future of Screening Programs

In this final module, important aspects of for the evaluation, planning and decision making about the implementation or stopping of screening programs will be presented. This material is given by Senior lecturer Jean-Luc Bulliard who is an epidemiologist in the Division of Chronic Diseases at the Institute for Social and Preventive Medicine in Lausanne. The conclusion of the module will be a series of interviews with experts on the future of disease screening in public health conducted by Dr. Gillian Bartlett-Esquilant, a visiting professor at the Institute for Social and Preventive Medicine at Lausanne. A quiz will close this module.

Module 8 introduction_new video3:44

Major Controversies with Screening Programs13:26

Evaluation of Screening Programs10:47

Bias in Screening Programs7:03

Planning a Screening Program, Part I10:49

Planning a Screening Program, Part II7:43

Example of a Decision Aid for Screening3:28

Screening Program Implementation13:13

Rencontrer les enseignants

Antoine Flahault
Professor of Public Health and Director of the Institute of Global Health (Faculty of Medicine, University of Geneva) and co-Director of Centre Virchow-Villermé (Université Paris Descartes)
University of Geneva and Université Paris Descartes – Sorbonne Paris Cité
Fred Paccaud (In Partnership with UNIGE)
Professor of epidemiology and public health and Director of the Institute of social and preventive medicine
Lausanne University Hospital
Gillian Bartlett-Esquilant
Professor of Epidemiology and Research and Graduate Program Director and Associate Chair for the Department of Family Medicine at McGill University.
University of Lausannne and McGill University

Welcome to the final module, module eight,

in the course Disease Screening in Public Health,

where you will learn how to evaluate and develop policies for screening programs.

We will conclude this module with an exploration of the topics

that will likely be the focus for screening programs in the future.

If you have finished module seven,

you will have learnt key concepts and areas of focus for screening programs worldwide,

you will understand the special issues that affects screening

of chronic disease in low to middle income countries,

and you will understand the special needs for screening of migrants.

This will be a solid basis for

this module that examines how to evaluate screening programs,

develop policies for the programs,

and what the future public health screening might look like.

In this module, we will look at

what information you need to make decisions about screening programs,

and what you may want to consider going forward.

This module is given by senior lecturer Jean-Luc Bulliard,

who is an epidemiologist in the division of

chronic diseases at the Institute for Social and Preventive Medicine in Lausanne.

The focus of this module is on making decisions about screening programs.

With this in mind, current controversies in screening will be explored,

the touch on the conflict between societal good versus individual harm and benefit,

the scientific dissent that exists around claims

of benefit and harm from different programs,

issues in communication about screening and how this can impact and form choice,

and finally, conflicts of interest that exist.

Methods to evaluate evidence

will be reviewed to ensure that in screening program planning,

evidence is reviewed, the balance of benefits and harms are evaluated,

and evaluations are completed using appropriate study designs.

The three significant biases that exist in screening programs namely: lead time,

length time, and overdiagnosis will be defined and discussed.

The module will then focus on the requirements for planning

that include: defining clear objectives,

creation of decision aids, defining operational policies,

setup of computerized information systems,

delineating the setting and required infrastructure support,

detailing of communications, setup of coordination and management,

plans for quality control, and finally,

inclusion of appropriate research programs.

The next lecture will provide a framework for

making decisions based on scientific evidence,

available resources, and current social values and

beliefs to determine whether to start or stop a screening program.

In the final lecture,

I will interview several experts on what they think

the future will be for disease screening in public health.

The learning objectives for this module are:

to describe different study designs that may be used for

evaluation of screening programs along with

important biases and controversies associated with screening programs,

to list the nine key resources needed for planning a screening program,

and to describe the characteristics of

decision making framework used for screening programs.

Thank you for your time and attention,

I hope you enjoyed this module.

Explorer notre catalogue

Rejoignez-nous gratuitement et obtenez des recommendations, des mises à jour et des offres personnalisées.

Coursera propose un accès universel à la meilleure formation au monde, en partenariat avec des universités et des organisations du plus haut niveau, pour proposer des cours en ligne.

© 2018 Coursera Inc. Tous droits réservés.

Télécharger dans l'App Store

Disponible sur Google Play